Penn IDS Central — Philadelphia, Pennsylvania

Penn IDS Central is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Penn IDS Central has participated in 1 clinical trials.

Therapeutic areas: Locally Advanced or Metastatic Solid Tumors, Genes, BRCA 1.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn IDS Central?

Penn IDS Central has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn IDS Central conducted?

Penn IDS Central has 1 clinical trials on record. Their work covers Locally Advanced or Metastatic Solid Tumors, Genes, BRCA 1.

Is Penn IDS Central accredited by Crixeo Health?

Penn IDS Central has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn IDS Central?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.